Brenner Martin's Form 4 filing
iBio, Inc. (IBIO) · filed Jun 22, 2023
- Accession no.
- 0001104659-23-073578
- Filed
- Jun 22, 2023
- Trade date
- Jun 21, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $2.85K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brenner MartinCIK 0001770235 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2023 | Common Stock | SSaleDisposed | −3,859 | $0.68 | −$2,624.12 | 253,736 | Direct | |
| Jun 21, 2023 | Common Stock | SSaleDisposed | −225 | $0.69 | −$155.25 | 253,511 | Direct | |
| Jun 21, 2023 | Common Stock | SSaleDisposed | −100 | $0.68 | −$68 | 253,411 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Interim Chief Executive Officer and Chief Scientific Officer